Comments
Aurobindo Pharma’s consolidated net profit declined 19 per cent to ₹ 404 crore in the fourth quarter ended March 31, 2015, against ₹502 crore in the corresponding quarter of previous financial year.
The total revenue of the Hyderabad-based company had increased 35.7 per cent at ₹3,162 crore (₹2,329 crore), as per the audited results declared on Thursday.
For the full year ended March, Aurobindo posted 34.3 per cent increase in the net profit at ₹1,576 crore (₹1,172 crore).
The total revenue too, increased to ₹12,120 crore (₹8,099 crore).
The board of directors had approved a bonus issue of shares of one equity share for every one equity share held by equity shareholders. Aurobindo’s scrip lost 2.57 per cent on the BSE on Thursday to close at ₹1304.15.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.